New Psychoactive Substances (NPS) is an umbrella term covering hundreds of substances
across different drug groups. Many of these substances were originally developed for …

New psychoactive substances (NPS) are chemical compounds designed to mimic the action
of existing illicit recreational drugs. Synthetic cannabinoids (SCs) are a subclass of NPS …

Synthetic cannabinoids (SCs) were initially developed as pharmacological tools to probe the
endocannabinoid system and as novel pharmacotherapies, but are now highly abused. This …

Synthetic cannabinoids are a group of compounds that act on the CB1 receptor and are
used illicitly as substitutes for cannabis. Given the rapid and extensive metabolism of …

The emergence of ever-novel psychoactive substances on the recreational drug market is
an ongoing challenge for analytical toxicologists. If still unknown, their structure must first be …

The occurrence of structurally related synthetic cannabinoids makes the identification of
unique markers of drug intake particularly challenging. The aim of this study was to identify …

Abstract A New Psychoactive Substance (NPS) is defined by United Nation Office of Drugs
and Drug Addiction (UNODC) as a “substance of abuse, either in a pure form or a …

The misuse of fentanyl, and novel synthetic opioids (NSO) in general, has become a public
health emergency, especially in the United States. The detection of NSO is often challenged …

The still increasing number of drugs of abuse, particularly the so-called new psychoactive
substances (NPS), poses an analytical challenge for clinical and forensic toxicologists but …

The phenomenon of new psychoactive substances is constantly evolving, with novel
synthetic opioids (NSOs) representing a fast growing subclass. From 2014 onwards, illicit …